“Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials ”, J of Skin, vol. 8, no. 2, p. s375, Mar. 2024, doi: 10.25251/skin.8.supp.375.